{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:34:00Z","timestamp":1793126040173,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejps.2026.107666","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:30:05Z","timestamp":1789666205000},"page":"107666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Overcoming formulation challenges of a moisture-sensitive API using tricalcium citrate TB and anhydrous trimagnesium citrate in direct compression"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1299-9338","authenticated-orcid":false,"given":"Maike","family":"Hafels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1818-4190","authenticated-orcid":false,"given":"David","family":"Maslennikow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6613-5440","authenticated-orcid":false,"given":"Amelie","family":"Mattusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-7191","authenticated-orcid":false,"given":"Karl G.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6921-0757","authenticated-orcid":false,"given":"Kristina E.","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107666_bib0057","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/jps.20411","article-title":"Role of water in the physical stability of solid dosage formulations","volume":"94","author":"Airaksinen","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0016","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0731-7085(01)00399-5","article-title":"Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations","volume":"25","author":"Al-Omari","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2026.107666_bib0044","first-page":"274","article-title":"Native starch in tablet formulations: properties on compaction","volume":"9","author":"Bos","year":"1987","journal-title":"Pharm. Weekbl."},{"key":"10.1016\/j.ejps.2026.107666_bib0018","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.xphs.2020.11.037","article-title":"Study on the mechanism responsible for the incompatibility of enalapril maleate with sodium starch glycolate","volume":"110","author":"Bout","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106121","article-title":"Influence of commonly used excipients on the chemical degradation of enalapril maleate in its solid state: the role of condensed water","volume":"171","author":"Bout","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0001","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4155\/bio.09.20","article-title":"Factors affecting the stability of drugs and drug metabolites in biological matrices","volume":"1","author":"Briscoe","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2026.107666_bib0031","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1175\/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2","article-title":"New equations for computing vapor pressure and enhancement factor","volume":"20","author":"Buck","year":"1981","journal-title":"J Appl Meteorol Clim."},{"key":"10.1016\/j.ejps.2026.107666_bib0032","unstructured":"Buck Research Instruments, LLC. Model CR-5 hygrometer operating manual, appendix 1: humidity conversion equations (revised 7\/96). Boulder, CO; 2009. https:\/\/www.hygrometers.com\/wp-content\/uploads\/CR-5-users-manual-2009-12.pdf. Accessed 10 Aug 2026."},{"key":"10.1016\/j.ejps.2026.107666_bib0059","first-page":"277","article-title":"Proposal of a new degradation mechanism of enalapril maleate and improvement of enalapril maleate stability in tablet formulation with different stabilizers","volume":"69","author":"Chen","year":"2014","journal-title":"Pharm. - Int. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0050","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.xphs.2015.12.019","article-title":"Review of disintegrants and the disintegration phenomena","volume":"105","author":"Desai","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0046","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/pharmaceutics13091486","article-title":"Comparison of flow and compression properties of four lactose-based co-processed excipients: Cellactose\u00ae 80, CombiLac\u00ae, MicroceLac\u00ae 100, and StarLac\u00ae","volume":"13","author":"Dominik","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107666_bib0047","article-title":"A corn starch\/a-lactose monohydrate compound as a directly compressible excipient | pharmaceutical technology","volume":"15","author":"Dressler","year":"2003","journal-title":"Pharm. Technol. Eur."},{"key":"10.1016\/j.ejps.2026.107666_bib0010","series-title":"BfArM. Europ\u00e4isches Arzneibuch - Amtliche deutsche Ausgabe. 11.0","year":"2023"},{"key":"10.1016\/j.ejps.2026.107666_bib0039","series-title":"BfArM. Monographie Tabletten. Eur Arzneib - Amtliche Dtsch Ausg. 11.0","year":"2023"},{"key":"10.1016\/j.ejps.2026.107666_bib0052","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijpharm.2018.07.025","article-title":"Competing for water: a new approach to understand disintegrant performance","volume":"548","author":"Ekmekciyan","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107666_bib0055","unstructured":"EMA. Q 6 A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. CPMP\/ICH\/367\/96. 2000; https:\/\/www.ema.europa.eu\/en\/ich-q6a-specifications-test-procedures-acceptance-criteria-new-drug-substances-new-drug-products-chemical-substances-scientific-guideline. Accessed 20 Aug 2026."},{"key":"10.1016\/j.ejps.2026.107666_bib0030","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jps.2600590523","article-title":"Determination of tablet strength by the diametral-compression test","volume":"59","author":"Fell","year":"1970","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0056","author":"Gruber"},{"key":"10.1016\/j.ejps.2026.107666_bib0022","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1208\/s12249-026-03360-3","article-title":"Tricalcium citrate tetrahydrate TB as filler in direct compression of minitablets","volume":"27","author":"Hafels","year":"2026","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2026.107666_bib0021","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1080\/03639045.2018.1483389","article-title":"Tricalcium citrate \u2013 a new brittle tableting excipient for direct compression and dry granulation with enormous hardness yield","volume":"44","author":"Hagelstein","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2026.107666_bib0043","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1208\/ps060216","article-title":"Evaluation of a new coprocessed compound based on lactose and maize starch for tablet formulation","volume":"6","author":"Hauschild","year":"2004","journal-title":"AAPS PharmSci."},{"key":"10.1016\/j.ejps.2026.107666_bib0007","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4236\/ajac.2016.71011","article-title":"Drug-excipient interactions: case studies and overview of drug degradation pathways","volume":"07","author":"Hotha","year":"2016","journal-title":"Am. J. Anal. Chem. Sci. Res. Publ.;"},{"key":"10.1016\/j.ejps.2026.107666_bib0023","unstructured":"Jungbunzlauer Suisse AG Tableting properties of trimagnesium citrate anhydrous GN. 2023. https:\/\/www.jungbunzlauer.com\/wp-content\/uploads\/2025\/04\/Tableting-properties-of-Trimagnesium-Citrate-Anhydrous-GN.pdf. Accessed 28 Jan 2026."},{"key":"10.1016\/j.ejps.2026.107666_bib0024","unstructured":"Jungbunzlauer Suisse AG Special salts - functional minerals 2017 https:\/\/www.jungbunzlauer.com\/de\/ingredients\/mineral-salts\/. Accessed 15 Sept 2025."},{"key":"10.1016\/j.ejps.2026.107666_bib0026","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40795-016-0121-3","article-title":"Higher bioavailability of magnesium citrate as compared to magnesium oxide shown by evaluation of urinary excretion and serum levels after single-dose administration in a randomized cross-over study","volume":"3","author":"Kappeler","year":"2017","journal-title":"BMC Nutr."},{"key":"10.1016\/j.ejps.2026.107666_bib0004","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2014.09.030","article-title":"Controlling the chemical stability of a moisture-sensitive drug product through monitoring and identification of coating process microenvironment","volume":"476","author":"Kestur","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107666_bib0020","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jpba.2008.02.030","article-title":"Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications","volume":"47","author":"Lima","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2026.107666_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120221","article-title":"Exploring the performance-controlling tablet disintegration mechanisms for direct compression formulations","volume":"599","author":"Maclean","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107666_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120382","article-title":"Tablet disintegration performance: effect of compression pressure and storage conditions on surface liquid absorption and swelling kinetics","volume":"601","author":"Markl","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107666_bib0051","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s11095-017-2129-z","article-title":"A review of disintegration mechanisms and measurement techniques","volume":"34","author":"Markl","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107666_bib0045","unstructured":"Meggle GmbH & Co. KG. Technical brochure- StarLac\u00ae. Wasserburg; 2023. https:\/\/www.meggle-excipients.com\/products\/starlac. Accessed 4 Feb 2026."},{"key":"10.1016\/j.ejps.2026.107666_bib0006","series-title":"Excipient Applications in Formulation Design and Drug Delivery","year":"2015"},{"key":"10.1016\/j.ejps.2026.107666_bib0003","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3390\/pharmaceutics14102015","article-title":"Formulation strategies to improve the stability and handling of oral solid dosage forms of highly hygroscopic pharmaceuticals and nutraceuticals","volume":"14","author":"Ng","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107666_bib0012","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0099-5428(08)60557-2","article-title":"Enalapril maleate","author":"P.Ip","year":"1987","journal-title":"Anal. Profiles Drug Subst."},{"key":"10.1016\/j.ejps.2026.107666_bib0040","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/jps.2600551015","article-title":"Mechanism of action of starch as a disintegrating agent in Aspirin tablets","volume":"55","author":"Patel","year":"1966","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0033","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/BF00547442","article-title":"Tensile fracture of doubly-convex cylindrical discs under diametral loading","volume":"23","author":"Pitt","year":"1988","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0049","first-page":"1","article-title":"A critical review on tablet disintegration","volume":"21","author":"Quodbach","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2026.107666_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116541","article-title":"In silico and in vitro screening for carcinogenic potential of angiotensin-converting enzyme inhibitors and their degradation impurities","volume":"469","author":"Regulska","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107666_bib0053","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/app13042358","article-title":"The degradation product of Ramipril is potentially carcinogenic, genotoxic mutagen","volume":"13","author":"Regulska","year":"2023","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0054","doi-asserted-by":"crossref","first-page":"551","DOI":"10.5603\/RPOR.a2023.0059","article-title":"Angiotensin-converting enzyme inhibitors for ovarian cancer? \u2014 A new adjuvant option or a silent trap","volume":"28","author":"Regulska","year":"2023","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"10.1016\/j.ejps.2026.107666_bib0015","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10973-007-8187-4","article-title":"Stability and compatibility study on enalapril maleate using thermoanalytical techniques","volume":"93","author":"Rezende","year":"2008","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ejps.2026.107666_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00045391-199911000-00005","article-title":"Meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate","volume":"6","author":"Sakhaee","year":"1999","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ejps.2026.107666_bib0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.proeng.2015.01.132","article-title":"Correlation between powder flow properties measured by shear testing and hausner ratio","volume":"102","author":"Saw","year":"2015","journal-title":"Procedia Eng."},{"key":"10.1016\/j.ejps.2026.107666_bib0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/pharmaceutics12030248","article-title":"The challenge of die filling in rotary presses\u2014a systematic study of material properties and process parameters","volume":"12","author":"Schomberg","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107666_bib0029","series-title":"Pulver und Sch\u00fcttg\u00fcter: Flie\u00dfeigenschaften und Handhabung","author":"Schulze","year":"2019"},{"key":"10.1016\/j.ejps.2026.107666_bib0017","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/03639045.2012.657644","article-title":"Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations","volume":"39","author":"Stanisz","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2026.107666_bib0038","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1163\/156855293X00042","article-title":"The relationships between powder flowability, particle re-arrangement, bulk density and Jenike failure function","volume":"4","author":"Stanley-Wood","year":"1993","journal-title":"Adv. Powder Technol."},{"key":"10.1016\/j.ejps.2026.107666_bib0034","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1208\/s12249-016-0655-3","article-title":"Powder flow testing: judicious choice of test methods","volume":"18","author":"Tay","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2026.107666_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124454","article-title":"A systematic comparison of four pharmacopoeial methods for measuring powder flowability","volume":"661","author":"Tharanon","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107666_bib0002","series-title":"Photostability of Drugs and Drug Formulations","author":"T\u00f8nnesen","year":"2004"},{"key":"10.1016\/j.ejps.2026.107666_bib0014","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2478\/v10007-012-0039-5","article-title":"Influence of different types of commercially available microcrystalline cellulose on degradation of perindopril erbumine and enalapril maleate in binary mixtures","volume":"62","author":"Vehovec","year":"2012","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejps.2026.107666_bib0011","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.xphs.2017.04.019","article-title":"Biowaiver monographs for immediate-release solid oral dosage forms: enalapril","volume":"106","author":"Verbeeck","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0008","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.xphs.2022.05.001","article-title":"Ensuring product stability \u2013 choosing the right excipients","volume":"111","author":"Veronica","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0009","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/acs.molpharmaceut.4c00031","article-title":"Understanding the roles of excipients in moisture management in solid dosage forms","volume":"21","author":"Veronica","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2026.107666_bib0058","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-5173(87)90217-1","article-title":"Studies on tableting properties of lactose. VIII. The effect of variations in primary particle size, percentage of amorphous lactose and addition of a disintegrant on the disintegration of spray-dried lactose tablets","volume":"39","author":"Vromans","year":"1987","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107666_bib0048","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1103\/PhysRev.17.273","article-title":"The dynamics of capillary flow","volume":"17","author":"Washburn","year":"1921","journal-title":"Phys. Rev."},{"key":"10.1016\/j.ejps.2026.107666_bib0005","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1002\/jps.22161","article-title":"Package selection for moisture protection for solid, oral drug products","volume":"99","author":"Waterman","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107666_bib0027","unstructured":"World Health Organization. The selection and use of essential medicines, 2025: WHO model list of essential medicines, 24th list. World Health Organization; 2025. 10.2471\/B09474."},{"key":"10.1016\/j.ejps.2026.107666_bib0037","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12247-016-9258-5","article-title":"Evaluation of small-scale powder flow characterization tests in the prediction of large-scale process failures","volume":"11","author":"Zettler","year":"2016","journal-title":"J. Pharm. Innov."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600240X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600240X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:53:47Z","timestamp":1793123627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872600240X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":59,"alternative-id":["S092809872600240X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107666","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming formulation challenges of a moisture-sensitive API using tricalcium citrate TB and anhydrous trimagnesium citrate in direct compression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107666"}}